Acute Rejection and Chronic Lung Allograft Dysfunction: Obstructive and Restrictive Allograft Dysfunction
Evidence level: narrative review; abstract-only
A review of acute cellular rejection and CLAD describes current knowledge, barriers and gaps in the greatest impediment to long-term survival.
As of . Primary source: Publisher record via DOI.
Summary
This Clinics in Chest Medicine review covers acute cellular rejection and chronic lung allograft dysfunction in its obstructive and restrictive forms. It states that lung recipients have the highest rates of acute and chronic rejection among solid organ transplants, and discusses current knowledge, barriers and gaps in acute cellular rejection and CLAD, which it calls the greatest impediment to long-term post-transplant survival.
Details
- doi
- 10.1016/j.ccm.2022.10.011
- pmid
- 36774160
- authors
- Beeckmans H, Bos S, Vos R, Glanville AR
- journal
- Clinics in Chest Medicine
- year
- 2023
- volume
- 44
- issue
- 1
- pages
- 137-157
Sources and links
- Publisher record via DOI (primary)
- PubMed 36774160
Related
Links from this record
- reviews: Acute cellular rejection
- reviews: Bronchiolitis obliterans syndrome (BOS)
- reviews: Restrictive allograft syndrome (RAS)
- authors affiliated with: KU Leuven BREATHE (Laboratory of Respiratory Diseases and Thoracic Surgery)
- coauthor: Robin Vos
Linked from (derived)
- author affiliation matches this institution (OpenAlex): Newcastle Lung Transplant Programme (Freeman Hospital and Newcastle University)
- author affiliation matches this institution (OpenAlex): St Vincent's Hospital Sydney Heart and Lung Transplant Unit
- author: Allan R. Glanville
- author: Robin Vos
- author: Saskia Bos
Known gaps in this record
- full text not read (abstract only)
- funding statement and grant numbers
- full text (not read)
- funding and conflicts of interest
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.